Taku Kato1, Kan Zen2, Osami Kawarada3, Koji Hozawa4, Hitoshi Anzai5, Hiroaki Nakamura6, Atsushi Funatsu7, Daizo Kawasaki8, Yoshinori Tsubakimoto9, Akihiro Higashimori10, Amane Kozuki11, Satoaki Matoba2. 1. Department of Cardiology, Rakuwakai Otowa Hospital, Kyoto, Japan. 2. Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. 3. Department of Cardiovascular Medicine, Ikuwakai Memorial Hospital, Osaka, Japan. 4. Department of Cardiology, Interventional Cardiology Unit, New Tokyo Hospital, Matsudo, Japan. 5. Department of Cardiology, Ota Memorial Hospital, Ota, Japan. 6. Department of Cardiology, Kakogawa Central City Hospital, Kakogawa, Japan. 7. Cardiovascular Center, Kyoto Katsura Hospital, Kyoto, Japan. 8. Cardiovascular Division, Department of Internal Medicine, Morinomiya Hospital, Osaka, Japan. 9. Department of Cardiology, Kyoto Second Red Cross Hospital, Kyoto, Japan. 10. Department of Cardiology, Kishiwada Tokusukai Hospital, Kishiwada, Japan. 11. Department of Cardiology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
Abstract
AIMS: The aim of this study was to evaluate the clinical outcomes of endovascular treatment (EVT) for chronic aortic occlusion (CAO) using multicentre registry data. METHODS AND RESULTS: From April 2003 to December 2015, data on 73 consecutive patients (55 men and 18 women; aged 70.7±12.2 years) who underwent EVT for CAO were collected retrospectively from 15 centres in Japan. The primary endpoint was the primary patency at 12 months after EVT. Secondary endpoints were procedural success and periprocedural complication rates. We analysed 67 patients who underwent complete endovascular revascularisation after 2007. Initial procedural success was achieved in 63 cases (94.0%). Complications occurred in three patients (4.5%) (stroke, n=1; distal embolism, n=1; access-site haematoma requiring blood transfusion, n=1). In patients after successful EVT (n=63), the primary and secondary patency rates at 12 months were 90.7% and 97.7%, respectively. During a mean follow-up period of 17.8 months, restenosis/re-occlusion was observed in eight patients (12.7%). CONCLUSIONS: EVT for CAO could be performed safely with a high procedural success rate. The short-term clinical outcome was acceptable despite lesion complexity.
AIMS: The aim of this study was to evaluate the clinical outcomes of endovascular treatment (EVT) for chronic aortic occlusion (CAO) using multicentre registry data. METHODS AND RESULTS: From April 2003 to December 2015, data on 73 consecutive patients (55 men and 18 women; aged 70.7±12.2 years) who underwent EVT for CAO were collected retrospectively from 15 centres in Japan. The primary endpoint was the primary patency at 12 months after EVT. Secondary endpoints were procedural success and periprocedural complication rates. We analysed 67 patients who underwent complete endovascular revascularisation after 2007. Initial procedural success was achieved in 63 cases (94.0%). Complications occurred in three patients (4.5%) (stroke, n=1; distal embolism, n=1; access-site haematoma requiring blood transfusion, n=1). In patients after successful EVT (n=63), the primary and secondary patency rates at 12 months were 90.7% and 97.7%, respectively. During a mean follow-up period of 17.8 months, restenosis/re-occlusion was observed in eight patients (12.7%). CONCLUSIONS: EVT for CAO could be performed safely with a high procedural success rate. The short-term clinical outcome was acceptable despite lesion complexity.
Authors: Charles A West; Lester W Johnson; Linda Doucet; Gloria Caldito; Maureen Heldman; Tibor Szarvas; Roger D Speirs; Sara Carson Journal: J Vasc Surg Date: 2010-08-21 Impact factor: 4.268
Authors: Kim Bredahl; Leif Panduro Jensen; Torben V Schroeder; Henrik Sillesen; Henrik Nielsen; Jonas P Eiberg Journal: J Vasc Surg Date: 2015-07 Impact factor: 4.268
Authors: Mireille A Moise; Javier A Alvarez-Tostado; Daniel G Clair; Roy K Greenberg; Sean P Lyden; Sunita D Srivastava; Matthew Eagleton; Timur S Sarac; Vikram S Kashyap Journal: J Endovasc Ther Date: 2009-02 Impact factor: 3.487